Background: The impact of left atrial posterior wall isolation (LAPWI) on the complex
and linear ablation, have been proposed, the outcomes of catheter ablation for persistent AF remain unsatisfactory. 5 The left atrial posterior wall embryologically originates from the same cells of the primordial pulmonary vein. 6 Moreover, the myocytes of the left atrial posterior wall have a relatively high incidence of delayed after-depolarizations because of their distinctive ion channel characteristics. 7 Consequently, focal discharges from the left atrial posterior wall play an important role as the non-pulmonary vein trigger for the initiation of AF. 8 Additionally, the complex structure of the left atrial posterior wall with the abrupt change in muscle fiber orientation contributes to the frequent finding of AF drivers and rotors. 9, 10 Left atrial posterior wall isolation (LAPWI) has been part of the surgical Maze procedure and has yielded good results as an open surgical procedure. 11 Although LAPWI is challenging to achieve with the use of endocardial catheter ablation, 12, 13 some previous studies have reported the effectiveness of LAPWI to suppress AF recurrence after catheter ablation. [14] [15] [16] [17] However, the mechanisms of the AF-suppressing effects of LAPWI are still unclear.
Complex fractionated atrial electrogram (CFAE), which demonstrates continuous fractionation and very short cycle lengths during AF, provides valuable information regarding the substrate of AF. 18 Therefore, assessment of changes in the CFAE areas after LAPWI may be useful for understanding the mechanisms of the AF-suppressing effects of LAPWI. Especially, changes in the CFAE areas in the right atrium, which is remote from the LAPWI lines, may provide new insights into the mechanisms of the AF-suppressing effects of LAPWI. Therefore, the aim of the present study was to assess the impact of LAPWI on the size and distribution of CFAE areas in persistent AF patients. In addition, the relationship between the CFAE areas and AF recurrence after catheter ablation was assessed.
| ME THODS

| Study population
The subjects enrolled in the present study comprised 46 patients with persistent AF and who underwent AF ablation at the Toyama University Hospital from November 2015 to October 2016.
Persistent AF was defined as AF lasting ≥ 7 days. 19 Patients with previous catheter ablation or previous heart surgery, those on hemodialysis, and those with thyroid and pulmonary diseases were excluded. The study protocol was approved by the Institution
Research and Ethics Committee of the University of Toyama and was conducted in accordance with the principles of the Declaration of Helsinki. We obtained written informed consent from the patients before performing catheter ablation.
| AF Ablation and CFAE mapping
All antiarrhythmic drugs were discontinued for at least five half-lives, and no patient received oral amiodarone before the ablation. Sheath introducers were inserted through the right femoral vein, with the patient under sedation. A transseptal procedure was performed; two 8-F SL0 
| Post-procedure care and follow-up
We conducted clinical interview and performed surface electrocardiogram on the day following the ablation and during monthly visits to the outpatient clinic thereafter. In addition, we performed 24-hour Holter monitoring on the day following ablation and as needed thereafter the follow-up period. Antiarrhythmic drugs were discontinued at the discretion of the treating physician. The followup was performed until 12 months after ablation. AF recurrence was defined as sustained AF lasting > 30 seconds, which occurred from 3 to 12 months after catheter ablation.
| Statistical analyses
The data were presented as mean ± standard error of the mean. The significance of the changes in the CFAE areas was analyzed using paired Student's t test. Patients were divided into two groups according to the presence of AF recurrence after catheter ablation.
The distribution of the CFAE areas was compared between the groups to assess the impact of the location of the CFAE areas on AF recurrence. The distribution of CFAE areas was defined as the proportion of CFAE areas in each segment of the atria relative to the cumulative CFAE areas. The significance of the differences between the groups was analyzed using unpaired Student's t-test for continuous variables and Fisher's exact probability test for categorical variables. The correlations between the surface area of LAPWI and changes in the CFAE areas were analyzed using the Pearson's correlation coefficient. A P < 0.05 was accepted as statistically significant.
| RE SULTS
| Patient characteristics and outcomes after catheter ablation
The baseline patient characteristics are shown in Table 1 . The mean AF duration was over 1 year. Over half of the patients had hypertension, and 20% had congestive heart failure. Left atrial appendage flow velocity deteriorated, but left atrial dilatation was mild.
Complex fractionated atrial electrogram mapping was completed in all patients because there was no spontaneous termination of the AF during the procedure. LAPWI was successfully performed in all patients. Ectopic activity originating inside LAPWI was observed in only one patient. After catheter ablation, AF recurred in nine patients (20%).
Three patients underwent a second catheter ablation procedure; in one of the patients, reconnection of the LAPWI was observed, and LAPWI was achieved during radiofrequency application on the floor line. The baseline patient characteristics were not different between the AF-recurrence and the AF-free groups (Table 1) .
| Changes in the CFAE areas after LAPWI
A representative case of the changes in the CFAE areas after LAPWI is shown in Figure 1 . The variable CFAE areas significantly decreased after LAPWI in both the left and right atria (Figure 2A,B) .
Therefore, the total variable CFAE area decreased after LAPWI ( Figure 2C ). The continuous CFAE areas did not change after LAPWI in the left atrium ( Figure 2D ), but they significantly decreased in right atrium ( Figure 2E ). Consequently, the total continuous CFAE areas significantly decreased after LAPWI ( Figure 2F ).
The mean surface area of LAPWI was 11 ± 1 cm 2 . Significant correlations between the surface area of LAPWI and changes in the variable (R = 0.017, P = 0.912) or continuous (R = 0.030, P = 0.843) CFAE areas were not observed.
| Changes in the regional CFAE areas after LAPWI
Both the variable and continuous CFAE areas were exclusively distributed on the anterior and septal walls of the left atrium and on the septal and lateral walls of the right atrium before LAPWI ( Figure 3A ,B). After LAPWI, the variable CFAE areas significantly decreased on the posterior, bottom, and roof walls of the left atrium 
TA B L E 1 Baseline patient characteristics
and on the posterior and bottom walls of the right atrium ( Figure 3A ).
The continuous CFAE areas significantly decreased on the posterior and bottom walls of the right atrium ( Figure 3B ).
| Comparison of the CFAE areas according to the recurrence of atrial fibrillation
The distribution of the variable CFAE areas did not differ between the groups before LAPWI ( Figure 4A ), but that on the anterior and septal walls of the right atrium became significantly larger in the AF-recurrence group than in the AF-free group after LAPWI ( Figure 4B ). The distribution of the continuous CFAE areas on the bottom wall of the right atrium was larger in the AF-recurrence group than in the AF-free group before LAPWI ( Figure 5A ), and this difference was maintained after LAPWI ( Figure 5B ).
| D ISCUSS I ON
In this study that assessed the impact of LAPWI on the CFAE areas, we found that LAPWI significantly decreased both the variable and continuous CFAE areas, not only in the posterior wall of the left atrium but also in the other segments of both the left and right atria. In particular, the CFAE areas on the bottom and roof walls of the left atrium and on the posterior and bottom walls of the right atrium significantly decreased. After LAPWI, a large distribution of the CFAE areas in the right atrium was associated with AF recurrence after catheter ablation.
| Mechanisms of decrease in the CFAE areas after LAPWI
The reduction of atrial myocardial mass may explain the decrease in the CFAE areas after LAPWI. 21, 22 LAPWI may have decreased AF drivers 
| Impacts of the CFAE areas on AF recurrence
In the AF-recurrence group, the distribution of the variable CFAE areas shifted from the left atrium to the right atrium after LAPWI. In 
| Clinical implication
Left atrial posterior wall isolation may unmask the potential AF substrates in the right atrium because the differences in the various CFAE areas appeared after LAPWI. In patients with large CFAE areas in the right atrium after LAPWI, suppression of AF recurrence is insufficient with LAPWI alone. A previous study reported that radiofrequency application to the CFAE areas, in addition to LAPWI and the anterior line, did not increase the AF freedom rate 24 ; however, the right atrial CFAE areas were not assessed in that study.
Therefore, the additional radiofrequency application targeting the right atrial CFAE areas might improve outcome. However, further studies are needed because a few studies 28 revealed the effectiveness of radiofrequency application targeting the right atrial CFAE areas.
| Limitations
Our study should be interpreted in the context of the following limitations. First, the number of patients included was too small to draw definite conclusions. Second, although the CFAEs are considered to represent the rapid electrical activity from the AF drivers, some may be a result of the dyssynchronous activation of separate cell groups at pivot points, wave collisions, or far-field potentials. 29 
| CON CLUS ION
Left atrial posterior wall isolation decreased the CFAE areas and changed the distribution of the CFAE areas. The remaining CFAE areas in the right atrium after LAPWI were associated with AF recurrence after catheter ablation.
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